Elbit's $270M ISR Contract Adds to Backlog but Valuation and ESG Risks Remain Unchanged

What happened

Elbit Systems announced it signed contracts valued at approximately $270 million with an international customer for advanced ISR and targeting payloads. This adds to the company's already substantial backlog, which stood at $25.2 billion as of Q3 2025. However, the stock trades at roughly 73x trailing EPS and 57x EV/EBITDA after a 142% price surge over the past year, already pricing in aggressive growth. ESG and political risks, including the UK training contract block and NSPA tender suspension, remain unresolved despite this commercial win. The contract reinforces demand but does not address the valuation or risk overhang.

Implication

The $270M contract confirms demand for Elbit's ISR and targeting technology, but it represents only about 1% of the backlog and does not materially alter the growth trajectory. At current levels, the stock already embeds sustained high-single to low-teens revenue growth and margin expansion, leaving little room for error. ESG and procurement risks, such as the UK training contract block and NSPA tender suspension, continue to threaten access to Western markets. We maintain a POTENTIAL SELL rating and would use any rally from this news to reduce exposure. The attractive entry remains near $500, with a re-assessment window of 6-12 months.

Thesis delta

The core thesis that ESLT is overvalued relative to its growth and risk profile remains unchanged. This contract win is consistent with the assumed demand backdrop and does not alter our probability-weighted scenarios. We reiterate the POTENTIAL SELL rating and $780 trim level, with no change to the attractive entry or re-assessment window.